Polyneuron Pharmaceuticals Ag Is A Clinical Stage Biotechnology Company Based In Baselswitzerlandfounded In 2014 As A Spinout From The University Of Baselthe Company Specializes In Developing Novel Therapies For Antibody Mediated Autoimmune Diseasesits Focus Is On Creating Antigen Specific Treatments That Neutralize Harmful Antibodies While Preserving The Immune System S Overall Function The Company S Key Technology Is The Antibody Catcha C Platformwhich Designs Injectable Polymers To Target And Eliminate Disease Causing Antibodiespolyneuron S Lead Candidatepn 1007Is An Investigational Therapy For Anti Mag Neuropathy And Has Received Orphan Drug Designation From The Emathe Company Is Currently Conducting Preclinical Studies To Prepare For Clinical Trialswith A Pipeline Aimed At Autoimmune Diseases Affecting The Nervous System And Potential Expansion To Other Conditionspolyneuron Has Raised Significant Funding And Collaborates With Academic Institutions To Advance Its Research
No conferences found for this company.
| Company Name | Polyneuron Pharmaceuticals Ag |
| Country |
Switzerland
|
| Address | N/A |
| Telephone | N/A |
| N/A |
